aTyr Pharma announced its results from San Diego on August 8, 2025.
3 reports, 3 independent
Updated Aug 1
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
aTyr Pharma announced its results from San Diego on August 8, 2025.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.aTyr Pharma reported its results from San Diego.1 source
aTyr Pharma is seeking FDA approval for its drug candidate.1 source
Keep exploring
The entities involved
-
aTyr Pharma
company in San Diego, United States
Nothing else this week.
-
San Diego
seat of San Diego County, California, United States; second-largest city in California
Related events
- enVVeno Medical plans to present its system in San Diego on November 2, 2026.
- SurModics announced a new product at a conference held in San Diego on October 26, 2026.
- AVR presented results at a conference in San Diego and confirmed it conducts clinical trials in the US and Australia.
- Salus Scientific Corp. will participate in TCT in San Diego on October 23, 2026.
Coverage
Newest first; wire copies grouped- manilatimes.net
- GlobeNewswireaTyr Pharma Announces Second Quarter 2025 Results and Provides Corporate Update Last patient visit completed in Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis; topline results expect
- Motley Fool1 Small-Cap Biotech Stock Poised for a Breakout Biotech stocks are showing signs of life after years of pressure from rate-driven factors, with several names posting significant gains following the r